| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/16/2007 | CN1315843C Derivant of Deacetoxy cephalosporanicacid, preparation and application |
| 05/16/2007 | CN1315842C Derivant of cephalosporin of amidinothioacetamide, preparation method and application |
| 05/16/2007 | CN1315840C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives used as drug for treating pain |
| 05/16/2007 | CN1315839C Benzothiophene [32-b] indole kind derivative, its preparation method and use |
| 05/16/2007 | CN1315838C 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 05/16/2007 | CN1315837C Salt of gambogicacid class compound, its preparation method, and medication combination with salt as active ingredient |
| 05/16/2007 | CN1315836C 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
| 05/16/2007 | CN1315835C Polycyclic guanine phosphodiesterase v inhibitors |
| 05/16/2007 | CN1315834C 6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 05/16/2007 | CN1315833C Azaindole kinase inhibitors |
| 05/16/2007 | CN1315832C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropydimido[1,2-a]pyrimidin-4-one derivatives |
| 05/16/2007 | CN1315830C Substituted purine new compound with anti-HIV activity, preparing method and use |
| 05/16/2007 | CN1315828C Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via 1H-imidazo [4,5-C] quinolin-4-phthalimide intermediates |
| 05/16/2007 | CN1315827C 1-(aminoalkyl)-3-sulfonylazaindoles as 5-hydroxytryptamine-6 ligands |
| 05/16/2007 | CN1315826C Process for preparing 3-(2-(4-(6-fluorobenzo(d) isoxazol-3-yl)-piperidin-1yl)-ethyl)-2-methyl-6,7,8,9-tetrahydro-4h-pyrido-(1,2-a) pyrimidin-4-one |
| 05/16/2007 | CN1315824C R- - -1- [2- 7-chlorobenzo [b] thiophen-3 -yl- methoxy -2- 2,4-dichlorophenyl -ethyl] -1h-imidazole |
| 05/16/2007 | CN1315822C Quinoline derivatives having VEGF inhibiting activity |
| 05/16/2007 | CN1315820C Thiophene carboxamides as inhibitors of the enzyme IKK-2 |
| 05/16/2007 | CN1315813C 2-amino-4h-3,1-benzoxazin-4-one derivatives for the treatment of obesity |
| 05/16/2007 | CN1315811C Pyrimidine derivatives and preparing method thereof |
| 05/16/2007 | CN1315809C Quinoline derivatives and their use as 5-HT6 ligands |
| 05/16/2007 | CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 05/16/2007 | CN1315805C Compositions and methods of use thereof achiral analogues of CC-1065 and duocarmycins |
| 05/16/2007 | CN1315803C Aminopyridyl-substituted phenyl acetamides as protease inhibitors |
| 05/16/2007 | CN1315770C Method and device for producing formic acid formates and use of said formates |
| 05/16/2007 | CN1315522C Medicine for treating tuberculosis, and its prodn. method |
| 05/16/2007 | CN1315517C Sucking tablet of gastrodia elata and its production method |
| 05/16/2007 | CN1315506C Chinese medicine preparation for treating gynecologic inflammation |
| 05/16/2007 | CN1315502C Drug-resistant rapid-acting eyedrops without stimulation |
| 05/16/2007 | CN1315492C Injection of Chinese medicinal agent possessing right supporting anticancer function and its preparation |
| 05/16/2007 | CN1315491C Natural cough stopping oral liquor |
| 05/16/2007 | CN1315484C Pharmaceutical vector composition for treating dermatopathy and process for preparing same |
| 05/16/2007 | CN1315483C Compositions internal or relevant improvement |
| 05/16/2007 | CN1315482C Inhibition of systemic infections in humans and vertebrates by dietary fibers |
| 05/16/2007 | CN1315481C Ginkgo leaf extract and its extracting method |
| 05/16/2007 | CN1315480C Herpes virus treating medicine composition and its production process |
| 05/16/2007 | CN1315479C Use of oleuropein in preparation of drug for inhibiting angiogenesis |
| 05/16/2007 | CN1315478C Composition for improving implantation rates after vitro fertilization and pharmaceutical use thereof |
| 05/16/2007 | CN1315477C Composition of cefuroxime sodium and tazobactam sodium for injection |
| 05/16/2007 | CN1315476C Anticarcinogen composition |
| 05/16/2007 | CN1315475C Soft capsule composition of compound cough-relieving and phlegm-eliminating medicine |
| 05/16/2007 | CN1315474C Use of ampelopsin in preparation of VEGF and bFGF inhibitor drug |
| 05/16/2007 | CN1315473C Therapeutic compositions |
| 05/16/2007 | CN1315471C Basis-reinforcing eyesight-improving dropping pill for treating eye disease and its preparing method |
| 05/16/2007 | CN1315454C Topical compositions for regulating oily/shiny appearance of skin |
| 05/16/2007 | CN1315413C Compositions for appetite control and related methods |
| 05/16/2007 | CN1315409C Materials and method for the treatment or prevention of obesity |
| 05/16/2007 | CN1315401C Preparation for lipoid frame particle |
| 05/16/2007 | CA2561436A1 Medicinal composition comprising 3-alkoxy-6-allythiopyridazines for prevention or treatment of cancer of the pancreas |
| 05/15/2007 | USRE39634 treatment of neuropathic pain; elevate levels of anandamide or other endogenous cannabinoids to increase the nociceptive threshold |
| 05/15/2007 | US7217844 Useful for inhibiting the growth of a cancer cell or neoplastic cell, or for inducing apoptosis in a cancer or neoplastic cell; reduced side effects |
| 05/15/2007 | US7217840 Method for preparing 1,3,5-triaminobenzene and hydrolyzing it into high-purity phloroglucinal |
| 05/15/2007 | US7217826 Making intermediates to alpha-ethyl-2-oxo-1-pyrrolidine acetamide, also referred to as levetiracetam an antihypoxic agent and antiischemic agent; by reduction via catalytic hydrogenation of an alkenyl intermediate |
| 05/15/2007 | US7217821 sunscreen agents; prevent radiation damage to skin, hair, lips |
| 05/15/2007 | US7217820 Protective coatings for skin, hair, for use as ultravilotet radiation filters in cosmetic or pharmaceutical preparations for protecting human skin or human hair against solar rays |
| 05/15/2007 | US7217819 Immobilization of taxane; anticancer, antitumor agents |
| 05/15/2007 | US7217817 Preparing a mixture containing an agarobiose-containing material of agar or purified agarose and a solid acid; decomposing the agarobiose-containing material by incubating the mixture at 50 100 degrees C. for 30 minutes to 12 hours; recovering an agarobiose-containing material |
| 05/15/2007 | US7217811 Human gene critical to fertility |
| 05/15/2007 | US7217805 Bicyclonucleoside analogues |
| 05/15/2007 | US7217770 Stable polymeric micelle-type drug composition and method for the preparation thereof |
| 05/15/2007 | US7217740 Diarylsulfones as 5-HT2A antagonists |
| 05/15/2007 | US7217739 D-penicillamine, amino guanidine, or 3 methyl-3 ethyl cysteine(MEC); to induce or to accelerate death of said abnormal cell; abnormal cell is a melanoma, a squamous carcinoma cell, an adenocarcinoma cell, an epithelial carcinoma cell, or a premalignant keratinocyte |
| 05/15/2007 | US7217738 β2-adrenergic receptor agonists |
| 05/15/2007 | US7217737 Method and compositions for inhibiting cell proliferative disorders |
| 05/15/2007 | US7217736 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 05/15/2007 | US7217735 Methods and compositions for enhancing delivery of therapeutic agents to tissues |
| 05/15/2007 | US7217734 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 05/15/2007 | US7217733 Cardiovascular disorders; kidney disorders; antiinflammatory agents |
| 05/15/2007 | US7217732 Cannabinoid receptor agonists |
| 05/15/2007 | US7217731 Hydroisoindoline tachykinin receptor antagonists |
| 05/15/2007 | US7217730 Method for the use of pyranoindole derivatives to treat infection with Hepatitis C virus |
| 05/15/2007 | US7217729 4,6-Dimethyl-3-{[3'-(N,N-dimethylaminomethyl)-4-hydroxy-4'-(3''-methoxyphenyl)-cyclohexylamino]-methyl}-1H-indole 2-carboxylic acid ethyl ester or other derivatives of substituted indoles; for treatment or prevention of neurodegenerative diseases, psychological disorders, AIDS, inflammation or allergies |
| 05/15/2007 | US7217728 For therapy of reperfusion injury |
| 05/15/2007 | US7217727 Phospholipase inhibitors |
| 05/15/2007 | US7217726 Oxazolidinon-3-ylphenyl -piperazine, -imidazolidine, and -diazepine derivatives, e.g., S)-N-[3-[3-Fluoro-4-[4-(5-nitrofuran-2-ylthiocarbonyl)piperazin-1-yl]phenyl]-2-oxooxazolidin-5-ylmethyl]thioacetamide; treating bacterial infections, particularly those that are antibiotic resistant |
| 05/15/2007 | US7217725 Prostaglandin D2 antagonist |
| 05/15/2007 | US7217724 2-[(2-hydroxy-2-pyridinylethyl)amino]ethyl-substituted indoles, e.g., N,N-Diethyl-2-{3-[(2R)-2-((2R)-2-hydroxy-2-pyridin-3-ylethylamino)-propyl]-1H-indol-7-yloxy}acetamide; beta 3-adrenoceptor stimulants, used for treating obesity, hyperglycemia, frequent urination, and urinary incontinence |
| 05/15/2007 | US7217723 Heterocyclic compound having oxime group |
| 05/15/2007 | US7217722 Nitrogen-containing compounds having kinase inhibitory activity and drugs containing the same |
| 05/15/2007 | US7217721 8-Azabicyclo[3.2.1]octane derivatives of 4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridines, used for modulating chemokine CCR5 receptors for treating retroviral infections and inflammatory diseases |
| 05/15/2007 | US7217720 Benzimidazolyl- or N-hetero analog derivatives of 4-aza-5 alpha -androstan-3-ones, e.g., beta -(1H-imidazo[4,5-c]pyridin-2-yl)-4-methyl-4-aza-5 alpha -androst-1-en-3-one; treatment of conditions caused by androgen deficiency |
| 05/15/2007 | US7217719 1,3,8-Triaza-spiro[4.5]decan-2-one compounds, e.g., (4S)/(4R)-4-(4-Fluorobenzyl)-3-(4-isobutoxybenzyl)-8-methyl-1,3,8-triaza-spiro [4.5]decan-2-one; treating schizophrenia, psychosis, migraine, hypertension, thrombosis, vasospasm, depression, anxiety, sleep and eating disorders |
| 05/15/2007 | US7217718 Administering an immunosuppressant; therapy for autoimmune disease |
| 05/15/2007 | US7217717 Antiproliferation agents; anticancer agents; tyrosine kinase inhibitor |
| 05/15/2007 | US7217716 Such as 4-((methyl-pyrimidin-2-ylamino)-methyl)-piperidine-1-carboxylic acid benzyl ester; useful for pain relief; treating migraine, depression, anxiety, schizophrenia, Parkinson's disease, and stroke; N-methyl-D-aspartate NR2B antagonists |
| 05/15/2007 | US7217715 Substituted 8-perfluoroalkyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives |
| 05/15/2007 | US7217714 1-(3-carboxamido-3-phenylpropyl)piperidin-4-yl -triazole or oxazole derivatives, for treatment and prevention of infection by HIV-1 and genetically related retroviruses |
| 05/15/2007 | US7217713 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 05/15/2007 | US7217712 4-Substituted-5-cyano-1H-pyrimidin-6-(thi)ones as GSK-3 inhibitors |
| 05/15/2007 | US7217711 Piperazin-1-yl and 2-([1,4]diazepan-1-yl)-imidazo[4,5-d]-pyridazin-4-ones, the preparation thereof and their use as pharmaceutical compositions |
| 05/15/2007 | US7217710 Pyrazolo-pyrimidine compound; anticancer agents |
| 05/15/2007 | US7217709 Tetracyclic benzamide derivatives and methods of use thereof |
| 05/15/2007 | US7217708 3,7-Diazabicyclo [3.3.1] formulations as anti-arrhythmic compounds |
| 05/15/2007 | US7217707 Amide of R-2-(aminoaryl)-propionic acid for use in the prevention of leucocyte activation |
| 05/15/2007 | US7217706 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 05/15/2007 | US7217705 synergistic effect; CB1 receptor antagonist is an azetidine compound of given formula such as N-{1-[bis(4-chlorophenyl)methyl]azetidin-3-yl}-N-(3,5-difluorophenyl)methylsulfonamide, and the dopaminergic agent is ropinirole or levodopa for example |
| 05/15/2007 | US7217704 LPA receptor agonists and antagonists and methods of use |
| 05/15/2007 | US7217703 For administration of bisphosphonates, e.g., alendronate, clodronate, etidronate, ibandronate, incadronate, minodronate, neridronate, olpadronate, pamidronate, risedronate, tiludronate, zoledronate, EB1053, or YH529, to treat various kinds of cancer |
| 05/15/2007 | US7217702 Adenine derivatives, especially substituted with an alkynylene-, alkenylene-, alkadienylene- or alkynylenealkenylene- group; e.g., 2-{3-[1-(Methoxycarbanoyl)piperidin-4-yl]propyn-1-yl}-9-propargyladenine; stimulating motor activity without dyskinesia; treating Huntington's & Parkinson's diseases, etc. |
| 05/15/2007 | US7217701 Intracellular calcium concentration increase inhibitors |